文献速递认知障碍与痴呆

性别差异在P-Tau217、Tau聚集与认知下降中的表现

Sex Differences in P-Tau217, Tau Aggregation, and Cognitive Decline.
PubMed 文献 · JAMA Neurol · 2026-01-01

该纵向研究分析5个队列1292名认知正常成人,探讨性别与聚集Aβ是否协同预测血浆p-tau217水平,以及p-tau217是否以性别特异性方式预测横断面和纵向Tau聚集。结果显示,在较高聚集Aβ Centiloid水平下女性基线p-tau217显著高于男性,且较高p-tau217水平下女性Tau沉积和累积更明显,认知下降更快。

要点

  • 较高聚集Aβ水平下,女性基线血浆p-tau217显著高于男性。
  • 较高p-tau217水平下,女性Tau PET沉积和纵向累积均高于男性。
  • 较高p-tau217水平下,女性认知下降速度相对男性更快。

核心结论

  • 女性对Aβ的Tau反应存在差异,可能出现在p-tau分泌阶段,对临床前阿尔茨海默病的诊疗有启示。

研究设计与样本

  • 纵向研究分析1个临床试验队列和4个观察性研究队列,共1292名认知正常成人,63.6%为女性,平均年龄70.6岁(SD 6.4)。
  • Tau PET平均随访3.6年(SD 1.7),认知数据来自5个队列中的3个,平均4.6年(SD 3.1)。
  • 主要分析采用线性模型和混合效应模型评估9个Tau PET脑区的基线及纵向性别×p-tau217交互作用。

主要发现

  • 较高聚集Aβ Centiloid水平下,女性基线p-tau217显著高于男性(β=-0.21,95%CI -0.37至-0.05,P=.009),交互作用在A4/LEARN队列最显著。
  • 基线性别×p-tau217交互作用在HABS队列1个脑区、A4/LEARN队列2个脑区、WRAP队列6个脑区、PREVENT-AD队列4个脑区显著。
  • 纵向交互作用在A4/LEARN队列4个脑区、ADNI和WRAP队列各5个脑区、HABS和PREVENT-AD队列各2个脑区显著。
  • 较高p-tau217水平下,女性Tau沉积和累积高于男性;WRAP和ADNI队列中女性认知下降更快。

临床怎么用

  • 临床前阿尔茨海默病评估中可关注性别对p-tau217与Tau PET关系的修饰作用。
  • 女性在较高Aβ负荷下p-tau217升高更明显,或可提示更密切的Tau病理和认知监测。

局限性

  • 认知数据仅来自5个队列中的3个,认知相关结论的普适性受限。
  • 原文未报告其他局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Among individuals with high levels of amyloid-β (Aβ), women exhibit higher insoluble tau burden and accumulation than age-matched men. It remains unclear whether this sex difference is influenced by soluble phosphorylated tau (p-tau), a biomarker that changes early in Alzheimer disease. OBJECTIVE: To investigate whether sex and aggregated Aβ synergistically predict plasma phosphorylated tau 217 (p-tau217) levels and whether levels of p-tau217 predict cross-sectional and longitudinal tau aggregation in a sex-specific manner (as measured by positron emission tomography [PET]). DESIGN, SETTING, AND PARTICIPANTS: This longitudinal study analyzed data between September 7, 2024, and October 29, 2025, from 1 clinical trial cohort and 4 observational study cohorts including men and women without cognitive impairment who had undergone multiple assessments via tau PET (18F-flortaucipir or 18F-MK-6240) and plasma p-tau217 assay at baseline. Cognitive performance was measured with the Preclinical Alzheimer Cognitive Composite. Data on cognitive performance were available from 3 of the 5 cohorts for a mean of 4.6 years (SD, 3.1 years). Across the 5 cohorts, the mean follow-up for tau PET was 3.6 years (SD, 1.7 years). EXPOSURES: Self-reported sex (male or female), tau PET, and p-tau217 assay. MAIN OUTCOMES AND MEASURES: The primary analyses used linear and mixed-effects models to assess baseline and longitudinal sex × p-tau217 interactions for 9 tau PET regions. The secondary analyses assessed sex × p-tau217 interactions for cognitive change using the Preclinical Alzheimer Cognitive Composite. RESULTS: Across the 5 cohorts, there were a total of 1292 participants (63.6% women; mean age, 70.6 [SD, 6.4] years) with tau PET assessments. Compared with men, women had significantly higher baseline p-tau217 levels at higher aggregated Aβ Centiloid levels (β, -0.21 [95% CI, -0.37 to -0.05], P = .009; highest interaction was found in the Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease/Longitudinal Evaluation of Amyloid Risk and Neurodegeneration [A4/LEARN] cohort). The sex × p-tau217 interactions at baseline were significant for 1 tau PET region in the Harvard Aging Brain Study (HABS) cohort, for 2 tau PET regions in the A4/LEARN cohort, for 6 tau PET regions in the Wisconsin Registry of Alzheimer's Prevention (WRAP) cohort, and for 4 tau PET regions in the Presymptomatic Evaluation of Experimental or Novel Treatments for Alzheimer's Disease (PREVENT-AD) cohort. Longitudinal interactions were significant for 4 tau PET regions in the A4/LEARN cohort, for 5 tau PET regions in both the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort and the WRAP cohort, and for 2 PET regions in both the HABS cohort and the PREVENT-AD cohort. Compared with men, women displayed greater tau deposition and accumulation at higher p-tau217 levels. Use of a secondary model showed women with higher p-tau217 levels also exhibited faster rates of cognitive decline relative to men in the both the WRAP cohort and the ADNI cohort. CONCLUSION AND RELEVANCE: These findings add to growing evidence that women have a differential tau response to Aβ that may emerge at the point of p-tau secretion. These findings have implications for the therapeutics and diagnostics of preclinical Alzheimer disease.

来源:JAMA Neurol,查看原文。版权归原作者所有。

引用

  1. Coughlan GT, Ourry V, Townsend D, et al. Sex Differences in P-Tau217, Tau Aggregation, and Cognitive Decline. JAMA Neurol. 2026. PMID: 41697669. doi:10.1001/jamaneurol.2025.5670

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。